Ovarian theca androgen production is regulated by the pituitary LH and intrafollicular factors. Enhanced androgen biosynthesis by theca cells contributes to polycystic ovary syndrome (PCOS) in women, but the ovarian consequences of elevated androgens are not completely understood. Our study documents the molecular events that are altered in the theca and stromal cells of mice exposed to high androgen levels, using the nonaromatizable androgen DHT. Changes in ovarian morphology and function were observed not only in follicles, but also in the stromal compartment. Genome-wide microarray analyses revealed marked changes in the ovarian transcriptome of DHT-treated females within 1 week. Particularly striking was the increased expression of vascular cell adhesion molecule 1 (Vcam1) specifically in the NR2F2/COUPTF-II lineage theca cells, not granulosa cells, of growing follicles and throughout the stroma of the androgen-treated mice. This response was mediated by androgen receptors (ARs) present in theca and stromal cells. Human theca-derived cultures expressed both ARs and NR2F2 that were nuclear. VCAM1 mRNA and protein were higher in PCOS-derived theca cells compared with control theca and reduced markedly by the AR antagonist flutamide. In the DHT-treated mice, VCAM1 was transiently induced by equine chorionic gonadotropin, when androgen and estrogen biosynthesis peak in preovulatory follicles, and was potently suppressed by a superovulatory dose of human chorionic gonadotropin. High levels of VCAM1 in the theca and interstitial cells of DHT-treated mice and in adult Leydig cells indicate that there may be novel functions for VCAM1 in reproductive tissues, including the gonads.
Pubmed ID: 30951142 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets alpha smooth muscle Actin
View all literature mentionsThis monoclonal targets Casp3
View all literature mentionsThis monoclonal targets Human COUP-TF II / NR2F2
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis polyclonal targets Collagen IV antibody
View all literature mentionsThis polyclonal targets Recombinant Full length Bovine P450c17 protein
View all literature mentionsThis monoclonal targets VCAM1
View all literature mentionsThis monoclonal targets Androgen Receptor
View all literature mentionsThis monoclonal targets F4/80 antibody [CI:A3-1]
View all literature mentionsThis monoclonal targets Vimentin
View all literature mentionsThis monoclonal targets F4/80 antibody [CI:A3-1]
View all literature mentionsThis monoclonal targets Androgen Receptor
View all literature mentionsThis monoclonal targets Vimentin
View all literature mentionsThis monoclonal targets Human COUP-TF II / NR2F2
View all literature mentionsThis monoclonal targets alpha smooth muscle Actin
View all literature mentionsThis polyclonal targets Collagen IV antibody
View all literature mentionsThis polyclonal targets Recombinant Full length Bovine P450c17 protein
View all literature mentionsThis monoclonal targets Casp3
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis monoclonal targets VCAM1
View all literature mentions